Herbert Kuster

3.5k total citations
59 papers, 2.4k citations indexed

About

Herbert Kuster is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Herbert Kuster has authored 59 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 44 papers in Virology and 15 papers in Immunology. Recurrent topics in Herbert Kuster's work include HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (29 papers). Herbert Kuster is often cited by papers focused on HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (34 papers) and HIV/AIDS Research and Interventions (29 papers). Herbert Kuster collaborates with scholars based in Switzerland, United States and Germany. Herbert Kuster's co-authors include Rainer Weber, Huldrych F. Günthard, Béda Joos, Alexandra Trkola, Marek Fischer, Christine Leemann, Peter Rusert, Hermann Katinger, Gabriela Stiegler and Jürg Böni and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Herbert Kuster

58 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Herbert Kuster Switzerland 27 1.5k 1.1k 661 492 390 59 2.4k
D. D. Richman United States 26 2.0k 1.3× 1.6k 1.4× 677 1.0× 1.1k 2.3× 527 1.4× 44 3.2k
Jan McClure United States 19 1.1k 0.7× 535 0.5× 483 0.7× 379 0.8× 293 0.8× 35 1.4k
Elizabeth A. Dragon United States 16 955 0.6× 586 0.5× 685 1.0× 689 1.4× 482 1.2× 22 2.0k
Michael S. Wyand United States 31 2.4k 1.6× 969 0.9× 2.1k 3.1× 1.3k 2.6× 817 2.1× 53 4.0k
Eva G. Rakasz United States 30 2.5k 1.7× 870 0.8× 2.2k 3.3× 778 1.6× 637 1.6× 102 3.6k
Martin Cranage United Kingdom 34 2.7k 1.8× 1.2k 1.1× 1.7k 2.6× 2.2k 4.5× 610 1.6× 98 4.3k
M. S. Hirsch United States 27 1.2k 0.8× 1.1k 1.0× 1.1k 1.6× 1.6k 3.2× 241 0.6× 42 3.3k
Sekhar Chakrabarti India 22 1.7k 1.2× 866 0.8× 1.0k 1.6× 1.2k 2.4× 540 1.4× 62 2.9k
Fernando Plata France 28 1.4k 0.9× 572 0.5× 1.7k 2.5× 1.0k 2.1× 308 0.8× 76 2.8k
Jeena Middel Netherlands 8 1.1k 0.8× 419 0.4× 1.3k 2.0× 378 0.8× 538 1.4× 8 2.2k

Countries citing papers authored by Herbert Kuster

Since Specialization
Citations

This map shows the geographic impact of Herbert Kuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Kuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Kuster more than expected).

Fields of papers citing papers by Herbert Kuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herbert Kuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Kuster. The network helps show where Herbert Kuster may publish in the future.

Co-authorship network of co-authors of Herbert Kuster

This figure shows the co-authorship network connecting the top 25 collaborators of Herbert Kuster. A scholar is included among the top collaborators of Herbert Kuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herbert Kuster. Herbert Kuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kouyos, Roger D., Herbert Kuster, Leonardo Aceto, et al.. (2024). Cohort Profile: The Zurich Primary HIV Infection Study. Microorganisms. 12(2). 302–302. 7 indexed citations
2.
Gianella, Sara, Merle Schanz, Roger D. Kouyos, et al.. (2024). Viral and Immune Risk Factors of HIV Rebound After Interruption of Antiretroviral Therapy. The Journal of Infectious Diseases. 231(5). 1221–1229. 2 indexed citations
3.
4.
Liechti, Thomas, Claus Kadelka, Dominique L. Braun, et al.. (2019). Widespread B cell perturbations in HIV-1 infection afflict naive and marginal zone B cells. The Journal of Experimental Medicine. 216(9). 2071–2090. 25 indexed citations
5.
Metzner, Karin J., Christine Leemann, Francesca Di Giallonardo, et al.. (2011). Reappearance of Minority K103N HIV-1 Variants after Interruption of ART Initiated during Primary HIV-1 Infection. PLoS ONE. 6(7). e21734–e21734. 8 indexed citations
6.
Rieder, P., Béda Joos, Alexandra Scherrer, et al.. (2011). Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection. Clinical Infectious Diseases. 53(12). 1271–1279. 64 indexed citations
7.
8.
Metzner, Karin J., Pia Rauch, Viktor von Wyl, et al.. (2010). Efficient Suppression of Minority Drug‐Resistant HIV Type 1 (HIV‐1) Variants Present at Primary HIV‐1 Infection by Ritonavir‐Boosted Protease Inhibitor–Containing Antiretroviral Therapy. The Journal of Infectious Diseases. 201(7). 1063–1071. 44 indexed citations
9.
Günthard, Huldrych F., Herbert Kuster, Cyril Shah, et al.. (2009). HIV‐1 Superinfection in an HIV‐2–Infected Woman with Subsequent Control of HIV‐1 Plasma Viremia. Clinical Infectious Diseases. 48(11). e117–e120. 23 indexed citations
10.
Joos, Béda, Philip Rieder, Marek Fischer, et al.. (2009). Association between specific HIV-1 Env traits and virologic control in vivo. Infection Genetics and Evolution. 10(3). 365–372. 1 indexed citations
11.
Joos, Béda, Marek Fischer, Herbert Kuster, et al.. (2008). HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proceedings of the National Academy of Sciences. 105(43). 16725–16730. 238 indexed citations
12.
Trkola, Alexandra, Herbert Kuster, Peter Rusert, et al.. (2007). In Vivo Efficacy of Human Immunodeficiency Virus Neutralizing Antibodies: Estimates for Protective Titers. Journal of Virology. 82(3). 1591–1599. 42 indexed citations
13.
Huber, Michael, Marek Fischer, Benjamin Misselwitz, et al.. (2006). Complement Lysis Activity in Autologous Plasma Is Associated with Lower Viral Loads during the Acute Phase of HIV-1 Infection. PLoS Medicine. 3(11). e441–e441. 89 indexed citations
14.
Trkola, Alexandra, Herbert Kuster, Peter Rusert, et al.. (2005). Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nature Medicine. 11(6). 615–622. 388 indexed citations
15.
Rusert, Peter, Marek Fischer, Béda Joos, et al.. (2004). Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol. Virology. 326(1). 113–129. 68 indexed citations
16.
Knuchel, Marlyse C., et al.. (2000). Incomplete HIV-1 Activation in Latently Infected U1 Cells Demonstrated by Double in Situ Hybridization. Virology. 271(1). 79–89. 1 indexed citations
17.
Weber, Rainer, Peter Deplazes, Markus Flepp, et al.. (1997). Cerebral Microsporidiosis Due toEncephalitozoon cuniculiin a Patient with Human Immunodeficiency Virus Infection. New England Journal of Medicine. 336(7). 474–478. 86 indexed citations
18.
Mathis, Alexander, et al.. (1996). Reliable One‐Tube Nested PCR for Detection and SSCP‐Typing of Pneumocystis carinii. Journal of Eukaryotic Microbiology. 43(5). 7S–7S. 6 indexed citations
19.
Grebski, Elzbieta, Erich W. Russi, Rudolf Speich, et al.. (1994). The Role of Two-Segment Bronchoalveolar Lavage in the Diagnosis of Pulmonary Infections. CHEST Journal. 106(2). 414–420. 6 indexed citations
20.
Weber, Rainer, Herbert Kuster, Govinda S. Visvesvara, et al.. (1993). Disseminated Microsporidiosis Due to Encephalitozoon hellem: Pulmonary Colonization, Microhematuria, and Mild Conjunctivitis in a Patient with AIDS. Clinical Infectious Diseases. 17(3). 415–419. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. D. Richman Breakdown of academic impact, for papers by Jan McClure Breakdown of academic impact, for papers by Elizabeth A. Dragon Breakdown of academic impact, for papers by Michael S. Wyand Breakdown of academic impact, for papers by Eva G. Rakasz Breakdown of academic impact, for papers by Martin Cranage Breakdown of academic impact, for papers by M. S. Hirsch Breakdown of academic impact, for papers by Sekhar Chakrabarti Breakdown of academic impact, for papers by Fernando Plata Breakdown of academic impact, for papers by Jeena Middel
Rankless by CCL
2026